Helen Sabzevari - 04 Jan 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: President and CEO, Director
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol: PGEN
Transactions as of: 04 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2023, 15:05:43 UTC
Previous filing: 15 Jun 2022
Next filing: 30 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Options Exercise		+17,665	+2%		914,756	04 Jan 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGEN	Restricted Stock Units	Options Exercise	$0	-17,665	-100%	$0.000000^*	0	04 Jan 2023	Common Stock	17,665		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2	The RSUs were granted on January 4, 2019 and January 25, 2019 and have vested in full.